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guidance and direction of their faculty
mentors [13]. Several excellent toolsiv
exist to assess these team skills and pro-
vide students the opportunity for self- and
peer evaluation and reﬂection [14].
Concluding Remarks
If synthetic biology is to maintain its
distinctive culture of collaboration and its
openness to sharing and to innovation, it is
up to us to instill these values in the stu-
dentswe teach. In thiswaywecancultivate
a new generation of synthetic biologists
who will hold true to its founding principles
and will be positioned to evolve with this
burgeoning and unique discipline.
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A Welcome Proposal
to Amend the GMO
Legislation of the EU
Dennis Eriksson,1,*
Wendy Harwood,2
Per Hofvander,1 Huw Jones,3
Peter Rogowsky,4 Eva Stöger,5
and Richard G.F. Visser6
Is the European Union (EU) regula-
tory framework forgeneticallymod-
iﬁed organisms (GMOs) adequate
for emerging techniques, such as
genomeediting? This hasbeendis-
cussedextensively formore than10
years. A recent proposal from The
Netherlands offers a way to break
thedeadlock.Here,wediscusshow
theproposalwouldaffectexamples
from public plant research.
New plant breeding techniques (NPBTs)
developedover thepast twodecadeshave
provided ample possibilities for efﬁcient
and elaborate plant research and trait
development. However, diverging stake-
holder opinions and politically motivated
arguments have left policy-makers in the
EU bereft of license to decide on their sta-
tus in relation to existing regulations. Some
EU member states have already been
compelled by various requests from seed
companies and public research groups to
interpret unilaterally the applicability of the
EU legislation to certainNPBTs. Therefore,
acknowledging the need for progress and
political resolution, The NetherlandsMinis-
try of Infrastructure and the Environment
recently proposedi to amend the EUDirec-
tive 2001/18/EC [1] on the deliberate
release into the environment of GMOs.
The Problem with the Current EU
GMO Legislation
Annex 1B of the EU Directive 2001/18/EC
lists techniques, such as mutagenesis,
resulting in GMOs that are excluded from
regulation by the Directive. There are two
problems here: the Directive contains no
deﬁnition of mutagenesis, and the deﬁni-
tion of GMO is somewhat ambiguous
because it refers to an organism ‘in which
the genetic material has been altered in a
way that doesnot occur naturally’. Another
complicating factor is that the national
translations of the Directive contain word-
ing regarding the deﬁnitions of GMO and
mutagenesis that may differ in interpreta-
tion, and an attempt at harmonization
would be desirable. A common interpreta-
tion among the scientiﬁc community of the
GMO deﬁnition, shared by us and others
[2], is that a certain techniquemay serve as
a trigger for the classiﬁcation as GMO, but
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that a certain outcome regarding the prod-
uct (i.e., the presence of a novel combina-
tion of stably inherited recombinant nucleic
acids) is also required foranorganism tobe
regulated under Directive 2001/18/EC.
However, not all stakeholders agree with
this interpretation, hampering the political
progress to decide on the regulation of
NPBTs.
A Proposal to Amend the EU
GMO Directive
The Dutch proposal does not seek to
reconcile the different interpretations of
the GMO deﬁnition per se, but merely
recommends a set of criteria to replace
the list of techniques in Annex 1B (Box 1).
Not all products resulting from the use of
NPBTs would be exempted; instead,
exemption would be based on the dual
condition that: (i) the resulting organism
does not contain recombinant nucleic
acids; and (ii) no genetic material other
than what could be exchanged through
traditional breeding methods is intro-
duced. It is not the ﬁrst proposal of this
kind to originate from The Netherlands. In
2006, a team at Wageningen University
and Research [3] suggested that cisgen-
esis, one of the eight NPBTs mentioned in
a report requested by the EU [4], should
be listed among the exemptions in Annex
1B. The new proposal is also consistent
with several reports delivered by The
Netherlands Commission on Genetic
Modiﬁcation (COGEM) [5–7].
Examples from Public Research
Institutes
We, being publicly funded academic
researchers, welcome the intentions of
the Dutch proposal because we acknowl-
edge that periodically updating the regu-
latory framework is instrumental in
responding to technical progress. Here,
we present examples of publicly funded
research, from our own or other institutes,
resulting in applications that may be
affected by the proposal if it were to be
adopted into EU legislation.
Austria
Several research programs have per-
formed targeted genome editing with the
CRISPR/Cas9 system. One example is
barley in which genomic fragment dele-
tions have been produced in the endo-
N-acetyl-b-D-glucosaminidase (ENGase)
gene [8] to alter glycoproteinmodiﬁcations
in cereal seeds. Additional target gene
knockouts in barley and Nicotiana species
include regulators of endoplasmic reticu-
lum (ER) stress andmetabolic pathways to
improve the suitability and performance of
plants for the production of pharmaceuti-
cally and industrially valuable compounds.
To the extent that the resulting plants do
not contain recombinant nucleic acids,
they would not be regulated as GMOs
according to the Dutch proposal.
France
The research project GENIUSii [127_TD$DIFF][126_TD$DIFF] (2012–
2019) implements genome editing as a
research and breeding tool in crops. Both
gene inactivation by random modiﬁca-
tions and allele replacement by speciﬁc,
matrix-based modiﬁcations have been
achieved at predetermined sites. The
traits chosen for proof of concept differ
between the nine species under investi-
gation (rice, wheat, maize, tomato,
potato, oilseed rape, poplar, apple, and
rose) and include disease resistance to
viruses and fungi, ﬂowering time, plant
architecture, tolerance to salinity, and
plant reproduction. These traits promote
a more sustainable agriculture by the
reduction of pesticides and the mitigation
of climate change. Following the Dutch
proposal, it is clear that several examples
developed in GENIUS would not be sub-
ject to the GMO regulation.
The Netherlands
The Durable Resistance against P. infes-
tans (DuRPh) project (2006–2016) aimed
to create cisgenic potatoes carrying mul-
tiple late blight-resistance genes from
crossable wild species. Plants carrying
different resistance genes in different vari-
etal backgrounds were created. Among
the events obtained via Agrobacterium
transformation, a few were identiﬁed car-
rying only the resistance genes with reg-
ulatory sequences and no other
(nonpotato) DNA sequences. Many differ-
ent events have been ﬁeld tested over the
years and remained unaffected by the
disease. Clean events (which are true to
type) are ideal cases for market introduc-
tion [9], because no other genetic material
is introduced other than what can be
exchanged through traditional breeding.
Sweden
Genomeediting is appliedonpotato via the
transfectionofprotoplastsandsubsequent
regeneration of plants, to produce tubers
with an improved starch quality for indus-
trial extraction. CRISPR/Cas9 and double-
stranded breaks with nonhomologous
end-joining (NHEJ) are utilized to achieve
mutations and enzyme function knockout,
and successful multiallelic mutations in
regenerated potatoplants havebeendem-
onstrated [10]. The resulting genetic
Box 1. The Original Intentions of the EU GMO Legislation
The Dutch proposal is compatible with the original intentions for GMO regulation in the EU [123_TD$DIFF] 13]. The 1988
draft for a Council Directive advertises ‘the commitment to update the Directive to technical progress as
necessary, given the rapid scientiﬁc development’ and declares further that ‘the Commission shall adapt the
annexes of this Directive to technical progress by amending new techniques’ [124_TD$DIFF] 14]. However, this provision
was not included in later Directives [125_TD$DIFF] 1,15]. Nearly 30 years of technical progress is arguably a compelling
reason to endow the current Directive with such a mechanism. When the GMO Directive was developed,
transgenesis mainly aimed at ectopic expression of foreign genes, whereas techniques such as genome
editing or RNA interference were not yet developed. Today, researchers and breeders use these and other
new breeding techniques, such as synthetic oligonucleotides or optimized alleles with very high similarity to
endogenous sequences, to alter the sequence or expression patterns of endogenous genetic material in
more subtle ways. Additionally, horizontal gene transfer occurs commonly in nature, and genotypes of a
given species can display more dissimilar genomes than may have been thought previously.
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alterations are not of recombinant type and
would not be regulated as GMO.
UK: England
Targeted gene knockouts are produced
using RNA-guided Cas9 in a range of
crops, including barley, wheat, Brassica
oleracea, Brassica napus, potato, and
tomato. This technology is valuable for
research on abiotic stress tolerance, dis-
ease resistance, aspects of plant develop-
ment,nitrogenuseefﬁciency, and foodand
feed quality. There are also real opportu-
nities for crop improvement. One example
is B. oleracea, where CRISPR/Cas9 has
been used to produce edited plants with
shatter-resistant pods to reduce losses
duringharvest (Figure1) [11]. In thecereals,
there is the potential to engineer drought
tolerance through speciﬁc mutations that
will affect the regulation of transcription
factors involved in the stress response.
These mutations would also, with the
Dutch proposal, lead to organisms that
are not regulated as GMOs.
UK: Wales
Lolium perenne, an important forage and
turf grass, has never been domesticated
to lose its innate seed-shattering pheno-
type. This is a major yield constraint for
the producers of certiﬁed seed, who cur-
rently must harvest the seeds before they
are fully mature or use other expensive
recovery methods. Homologs of shatter-
ing genes are identiﬁed in L. perenne and
single base-pair substitutions yield a non-
shattering phenotype. Grasses are out-
breeding polyploids that are bred as
families rather than as individuals, which
makes this trait intractable using conven-
tional methods. This breeding bottleneck
is being overcome by using CRISPR/
Cas9 gene editing to make this conver-
sion in elite L. perenne germplasm, with-
out introducing any recombinant nucleic
acids.
Complications and Prospects
Although the resulting plants in many of
the examples presented above would
have only point mutations or deletions
in endogenous genes, or the addition
of genetic material from crossable spe-
cies, both public and private breeders,
including in particular small and medium-
sized enterprises, would understandably
be reluctant to incorporate this material
into their breeding populations if it would
then be regulated as a GMO. Hence,
there is a risk that over-regulation of
emerging gene technologies will lead to
lost opportunities for improved crops.
We are of the opinion that many of the
above presented examples may already
not be covered by GMO regulations
under the current Directive, but the
Dutch proposal to amend Annex 1B
(D)  
Edited:       …CGCCGCTCCTTCCCCTCT– GCCGCAAGTGAAACATCCC… 
(B)Wild-type valve margin (C) Faulty valve margin
Wild-type Edited
(A)
Wild-type: …CGCCGCTCCTTCCCCTCCGGCCGCAAGTGAAACATCCC…
Figure 1. Genome Editing to Reduce Pod Shatter inBrassicaCrops. (A) Awild-typeBrassica oleracea
plant and a CRISPR/Cas9 mutant showing the expected dwarf phenotype. (B) Section through the pod of a
wild-type plant showing the normal valve margin. (C) Section through the pod of a CRISPR mutant plant
showing the faulty valve margin. (D) Part of the sequence of the BolC.GA4.a gene, showing the target site in the
wild-type (gray box with PAMmotif in red) and a mutant allele showing the change in red. Wild-type and edited
plants in (A) adapted from [11].
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would provide necessary clariﬁcation
beyond doubt for all stakeholders.
The proposal is not free from complica-
tions. Some stakeholders are reluctant to
open up the EU GMO legislation for
amendments, because such a process
could take many years, during which
the plant research and breeding sector
would lack a clear vision for commercial
applications. Opening up the Directive
might also lead to increased regulation
of so-called ‘conventional breeding tech-
niques’, which would be detrimental to
the entire seed sector. The proposal
may be untimely because all attention is
presently directed towards a European
Court of Justice case on mutagenesis
(C528/16), which may be decisive for cer-
tain applications of genome editing [12].
However, this court case is limited in
scope and will not resolve the issue of
NPBTs other than applications of nucle-
ase- or nucleotide-directed mutagenesis.
It is also argued that amending Annex 1B
is unnecessary since, according to a
common interpretation, Directive 2001/
18/EC is already sufﬁciently clear to man-
age NPBTs. However, more than 10
years of discussions demonstrate that
this is not the case. Although it may still
suffer from shortcomings, the Dutch pro-
posal is a welcome approach to initiate a
dialog at the EU level and may offer the
possibility for the research at our insti-
tutes, together with many others, to
deliver beneﬁts to farmers, the environ-
ment, and society.
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Coating with Microbial
Hydrophobins: A Novel
Approach to Develop
Smart Drug
Nanoparticles
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Microbial hydrophobin (MH)-
based surface coating is emerging
as a novel protein engineering
approach for drug nanoparticles
to enhance the solubility and sta-
bility of therapeutic agents. These
hydrophobins are amphiphilic pro-
teins that can form self-assembled
monolayers on hydrophobic mate-
rials and can coat nanoparticles for
efﬁcient drug delivery.
Drug Molecules and
Nanoparticles
Targeted and controlled drug delivery is a
key challenge in modern medicine, espe-
cially for anticancer drugs due to their
severe off-target effects andpoor aqueous
solubility [1,2]. Moreover, issues of phar-
macodynamics (how a drug affects an
organism) and pharmacokinetics (how
the organism affects the drug) are also
important concerns for drug delivery that
prevent many highly promising drugs from
reaching commercialization [3]. Therefore,
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